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Abstract
Several risk factors have been identified as potential contributors to pancreatic cancer development, including
environmental and lifestyle factors, such as smoking, drinking and diet, and medical conditions such as diabetes and
pancreatitis, all of which generate oxidative stress and DNA damage. Oxidative stress status can be modified by
environmental factors and also by an individual’s unique genetic makeup. Here we examined the contribution of
environment and genetics to an individual’s level of oxidative stress, DNA damage and susceptibility to pancreatic cancer in
a pilot study using three groups of subjects: a newly diagnosed pancreatic cancer group, a healthy genetically-unrelated
control group living with the case subject, and a healthy genetically-related control group which does not reside with the
subject. Oxidative stress and DNA damage was evaluated by measuring total antioxidant capacity, direct and oxidative DNA
damage by Comet assay, and malondialdehyde levels. Direct DNA damage was significantly elevated in pancreatic cancer
patients (age and sex adjusted mean 6 standard error: 1.0060.05) versus both healthy unrelated and related controls
(0.7060.06, p,0.001 and 0.8260.07, p = 0.046, respectively). Analysis of 22 selected SNPs in oxidative stress and DNA
damage genes revealed that CYP2A6 L160H was associated with pancreatic cancer. In addition, DNA damage was found to
be associated with TNFA 2308G.A and ERCC4 R415Q polymorphisms. These results suggest that measurement of DNA
damage, as well as select SNPs, may provide an important screening tool to identify individuals at risk for development of
pancreatic cancer.
Citation: Hocevar BA, Kamendulis LM, Pu X, Perkins SM, Wang Z-Y, et al. (2014) Contribution of Environment and Genetics to Pancreatic Cancer
Susceptibility. PLoS ONE 9(3): e90052. doi:10.1371/journal.pone.0090052
Editor: Klaus Roemer, University of Saarland Medical School, Germany
Received November 22, 2013; Accepted January 27, 2014; Published March 20, 2014
Copyright:  2014 Hocevar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded in part by the Indiana University Simon Cancer Center Translational Research Acceleration Collaboration (EGC), the Robert B.
Forney professorship (JEK), R01 CA100908 (JEK), and P30 CA82709 (SMP). The funders had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jklauni@indiana.edu (JEK); gchiorea@uw.edu (EGC)
Introduction
Pancreatic cancer, the fourth leading cause of cancer deaths in
the United States, is characterized by rapid metastasis and
profound resistance to chemo- and radiotherapy. Detection late
in the disease course and limited treatment options contribute to
its poor prognosis [1], with median 5 year survival rates of 6% [2].
As environmental factors play a significant role in the etiology of
sporadic pancreatic cancer [3], identification of gene-environment
interactions that contribute to pancreatic cancer oncogenesis is
essential for disease prevention. Further, development of diagnos-
tic tests which can identify susceptible individuals or monitor
disease progression may aid in prevention or guide pancreatic
cancer treatment.
In addition to chronic pancreatitis and diabetes, several lifestyle
risk factors have been linked to the development of pancreatic
cancer, including smoking, heavy alcohol consumption, and
obesity [3,4]. A common feature of these risk factors is their
ability to induce oxidative stress and DNA damage [5]. Oxidative
stress is defined as an imbalance between the production of
reactive oxygen species (ROS) and their elimination and repair by
cellular defense mechanisms. By causing damage to lipid, protein,
and DNA, ROS contribute to the pathology observed in chronic
inflammatory conditions, aging, and cancer [6–9]. Cellular
defense mechanisms exist to both repair damaged DNA and
detoxify ROS. Oxidatively modified bases and single-strand DNA
breaks are primarily repaired by the base excision DNA repair
(BER) pathway, while bulky adducts are repaired by the nucleotide
excision repair (NER) pathway [10]. Enzymatic antioxidants such
as superoxide dismutase (SOD), nitric oxide synthase (NOS),
catalase (CAT) and non-enzymatic antioxidants such as glutathi-
one, vitamin C and vitamin D serve to neutralize ROS [6].
Biological markers which quantify oxidative stress include
measurements of total antioxidant capacity (TAC), lipid peroxi-
dation products, such as malondialdehyde (MDA), and DNA
damage, which is commonly assessed by the Comet assay [11]. In
circulating peripheral blood mononuclear cells (PBMCs), in-
creased DNA damage has been observed in cigarette smokers
[12], and in type 2 diabetic patients which correlated
with hyperglycemia [13,14]. Increased lipid peroxidation levels,
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concomitant with decreased TAC, were also seen in patients with
type 2 diabetes and chronic pancreatitis [14,15]. With respect to
pancreatic malignancies, activation of the DNA damage response
pathway has been documented in pre-cancerous pancreatic
intraepithelial neoplasia [16], and dysregulation of oxidative
stress-related pathways such as Nrf2/Keap1 have been observed
in pancreatic cancer cell lines and human tumors [17].
An individual’s oxidative stress level depends on lifestyle
determinants, such as smoking, drinking and diet, and is also
influenced by genetics. Several case-control studies have investi-
gated the correlation of single nucleotide polymorphisms (SNPs) in
genes related to carcinogen metabolism, oxidative stress and DNA
repair, with pancreatic cancer. While SNPs in the phase I and II
metabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 alone did
not correlate with pancreatic cancer risk, a significant interaction
between smoking and the GSTT1 null genotype was reported in
Caucasian pancreatic cancer subjects [18]. Investigation of the
NER pathway revealed an association of SNPs in the MMS19L
gene with pancreatic cancer risk [19]. A decreased pancreatic
cancer risk was observed for carriers of ERCC4 R415Q and LIG3
G-39A minor alleles, while an increased risk was observed for the
ATM D1853N allele [20,21]. Polymorphisms in DNA repair genes
have also been linked to pancreatic cancer risk in the context of
exposure to smoking or individual history of diabetes [20,22].
However, other studies failed to identify direct correlations of
SNPs in metabolism and DNA repair genes with pancreatic cancer
risk [23,24]. The present pilot study examines the role of
environmental factors and genetics in pancreatic carcinogenesis
by evaluating biological measurements of oxidative stress, DNA
damage, and specific lifestyle factors and genetic polymorphisms
among groups of pancreatic cancer patients and healthy geneti-
cally related and unrelated controls.
Materials and Methods
Ethics Statement
This study was approved by the Indiana University Institutional
Review Board. Written informed consent was obtained from
participants.
Study Population
A total of 31 patients (cases) with pathologically confirmed
pancreatic cancer (Stages I–IV) and 40 healthy controls (20
genetically related and 20 unrelated) were enrolled. Cases were
excluded if they had a history of other malignancies, or had
already received treatment with chemotherapy or radiotherapy.
Cases were matched with either genetically related controls and/
or genetically unrelated controls. These distinct control groups
were recruited in order to discern the contribution of environ-
mental and genetic factors in pancreatic cancer risk. Genetically
related controls were included provided they did not live with their
matched case while genetically unrelated controls had to be
cohabiting with the case. All enrolled participants were Caucasian,
$18 years at time of consent, and able to understand and sign a
written informed consent. Information concerning subject demo-
graphics, behavioral factors (diet, smoking, alcohol, occupational
exposures), and personal and family medical history were obtained
by self-report using a questionnaire at the time of enrollment.
Cumulative smoking was calculated as pack-years [(packs/day)x(-
years smoked)]. Alcohol consumption was reported as days
drinking in the past year. Body mass index (BMI, kg/m2) was
calculated from self-reported height and weight or patient’s charts.
Blood samples were obtained from participants at the time of
enrollment.
Measurement of Total Antioxidant Capacity
Total antioxidant capacity (TAC) was measured in serum as
described [25]. A standard curve was generated using Trolox
(Sigma, St. Louis, MO) and TAC quantified from the standard
curve.
Assessment of Direct and Oxidative DNA Damage: Comet
Assay
Whole blood (10 ml) was mixed with 0.5 ml RPMI 1640
containing 10% FBS, 10% DMSO, 1 mM deferoxamine, step-
frozen and stored at 280uC until analysis. The Comet assay
was performed as described previously [26]. Briefly, 6 ml of
blood was mixed with 70 ml 1% low melting point agarose and
applied onto Trevigen CometSlidesH. Cells were lysed, placed
in alkali buffer, and then electrophoresed. Slides were stained
with ethidium bromide and 100 randomly selected nuclei/
sample were evaluated (Komet 4.0; Kinetic Imaging Ltd.,
Liverpool, UK). Oxidative DNA damage was assessed using
enzymatic digestion with formamidopyrimidine-DNA glycosy-
lase (fpg) prior to electrophoresis. DNA damage was
expressed as Comet (Olive) tail moment [(tail mean – head
mean)*tail%DNA/100].
Measurement of Malondialdehyde (MDA)
MDA was measured in serum using high performance liquid
chromatography (HPLC) with UV detection as described previ-
ously [27].
DNA Isolation and Genotyping
Genomic DNA was extracted from PBMCs in whole blood
using QIAamp DNA Blood Midi kit (Qiagen). Determination of
SNPs by allelic discrimination was performed using TaqMan
validated probes (Applied Biosystems) on an ABI 7900HT
instrument according to manufacturer’s instructions. The
SNPs were selected based on their previously reported
associations with oxidative stress status, DNA damage, and
cancer risk.
Statistical Analysis
Generalized and linear mixed models that accounted for the
correlations between patients and controls were used to
compare demographic, environmental factors, and chronic
pancreatitis and other inflammatory conditions between the
three arms. Oxidative stress and DNA damage measures were
compared between the pancreatic cancer patients and healthy
unrelated or healthy related controls and correlated with
environmental factors and SNPs (dominant, recessive, and gene
dose models) using linear mixed models adjusting for age and
sex due to group differences in these demographics. Adjusted
means 6 standard errors are reported from these models. Hardy
Weinberg equilibrium test was conducted to check the genotype
QC. Genetic risk of pancreatic cancer was assessed by
comparing SNP frequencies between patients and unrelated
healthy controls using Fisher exact tests (for dominant and
recessive genetic models) or Mantel-Haenszel Chi-square exact
tests (for gene dose models). All analyses were performed using
SAS Version 9.3 (Cary, NC). P-values of ,0.05 were
considered statistically significant. The purpose of this pilot
study was to generate hypotheses, especially genetic signals.
Therefore, the type I error was not stringently controlled in
multiple-comparisons.
Environment and Genetics in Pancreatic Cancer
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Results
Study Subject Characteristics
Demographic characteristics of the case and control subjects are
shown in Table 1. Cases were significantly older than the healthy
related control group; however, age of the healthy unrelated
control group was similar to that of the cases. Cases were more
likely to be male compared to both control groups while BMI was
similar between all groups. Both healthy unrelated and related
controls were more likely to be never-smokers compared to
pancreatic cancer cases (53% and 67% versus 38%, respectively)
although the differences were marginally significant (p = 0.07).
Smoking $20 pack years was similar in cases and healthy
unrelated controls compared to healthy related controls. Alcohol
consumption in the past year was not statistically different among
the groups. Chronic pancreatitis and other inflammatory condi-
tions, which included chronic pancreatitis, diabetes, and inflam-
matory bowel disease, were significantly increased in pancreatic
cancer patients.
Association of Pancreatic Cancer and Biomarkers of
Oxidative Stress
An oxidative stress/damage profile was generated from blood
samples of all enrolled participants (Table 2). Total antioxidant
capacity (TAC), measured by the Trolox-equivalent antioxidant
assay, was similar between pancreatic cancer cases and healthy
unrelated controls. In contrast, cases exhibited higher TAC levels
compared to healthy related controls; however, this difference was
not significant. Levels of the lipid peroxidation product MDA were
similar in pancreatic cancer cases compared to the healthy
unrelated controls and were higher in cases versus healthy related
controls, but did not achieve significance.
The alkaline Comet assay, that measures single and double
DNA strand breaks, was used to assess direct DNA damage in
PBMCs of cases and controls. Oxidative DNA damage was
determined by a modified Comet assay which included incubation
of the sample with formamidopyrimidine-DNA glycosylase (fpg)
prior to electrophoresis. Fpg recognizes oxidatively modified
purines and introduces additional DNA strand breaks, thus the
difference between fpg-modifed and un-modified Comet measure-
ments corresponds to oxidatively damaged DNA. As shown in
Table 2, oxidative DNA damage was higher in pancreatic cancer
cases versus both healthy unrelated and healthy unrelated controls;
however, differences were not statistically significant. Levels of
direct DNA damage were significantly elevated in cases
(1.0060.05) versus both healthy unrelated and related controls
(0.7060.06, p,0.001 and 0.8260.07, p= 0.046, respectively).
Table 1. Demographics and Risk Factors by Study Arm.
Pancreatic Cancer Cases
(n=31)
Healthy Unrelated Control
(n = 20)
Healthy Related Control
(n =20) p-value
Age
Mean 6 SD 64.969.6 62.1611.2 48.8612.1 ,.001
Range 46–84 45–87 20–69
Sex
Male 19 (61%) 5 (25%) 5 (25%) .01
Female 12 (39%) 15 (75%) 15 (75%)
BMIa
Mean 6 SD 2565 2866 2765 .09
Range 17–37 17–42 21–38
Smokinga: n (%)
Never 11 (38%) 10 (53%) 12 (67%) .07
Former 10 (34%) 4 (21%) 5 (28%)
Current 8 (23%) 5 (26%) 1 (6%)
,20 pack years 19 (66%) 13 (68%) 15 (83%) .23
$20 pack years 10 (34%) 6 (32%) 3 (17%)
Alcohol, past year consumptiona: n (%)
#7 days 15 (52%) 10 (52%) 8 (44%) .72
8–30 days 5 (17%) 6 (32%) 5 (28%)
.30 days 9 (31%) 3 (16%) 5 (28%)
Chronic Pancreatitisb: n (%)
Yes 7 (23%) 0 (0%) 1 (5%) .03
No 23 (77%) 19 (100%) 18 (95%)
Inflammatory Conditionsb: n (%)
Yes 13 (43%) 3 (16%) 3 (16%) .02
No 17 (57%) 16 (84%) 16 (84%)
aMissing data for 2 pancreatic cancer cases; 1 healthy unrelated control; and 2 healthy related controls;
bMissing data for 1 pancreatic cancer case; 1 healthy unrelated control; and 1 healthy related controls.
doi:10.1371/journal.pone.0090052.t001
Environment and Genetics in Pancreatic Cancer
PLOS ONE | www.plosone.org 3 March 2014 | Volume 9 | Issue 3 | e90052
Next, we examined potential correlations between known
pancreatic cancer risk factors and oxidative stress biomarkers
(Table 3). All correlations were adjusted for age and sex.
Correlations between smoking and oxidative stress markers did
not achieve statistical significance with the exception of direct
DNA damage, where a significant negative correlation was noted
(rs =2.29, p= .02). No significant associations were observed
between days drinking and TAC, direct, or oxidative DNA
damage. No correlations between oxidative stress markers and
chronic pancreatitis were observed; however, overall, inflamma-
tory conditions were associated with elevated levels of MDA
(p= 0.048).
Association of Pancreatic Cancer and Direct DNA
Damage with SNP Expression
The genotype of 22 SNPs in 17 genes involved in oxidative
stress, inflammation, DNA damage, methionine/folate metabo-
lism and carcinogen metabolism was determined in pancreatic
cancer cases and control groups (Table S1). Analysis of the
contribution of individual SNPs to pancreatic cancer was
determined by comparing SNP genotype in cases versus healthy
unrelated controls (Table 4). The CYP2A6 L160H major allele was
associated with pancreatic cancer overall (p = 0.03), as well as
exhibiting significance for dominance, recessive and gene dose
effects.
Since direct DNA damage was significantly elevated in
pancreatic cancer cases compared to both control groups, the
correlation between SNP genotype and this biomarker were
analyzed (Tables 5 and 6). The AA variant of the TNF2308 G.A
SNP exhibited a significant recessive effect (p = 0.003). The
ERCC4 R415Q polymorphism demonstrated significant dominant
and gene dose effects (p = 0.009). For both genes, the minor allele
resulted in a significant elevation in direct DNA damage (Table 6).
The AA variant of the TNFA 2308 G.A SNP was observed in
only 2 subjects with a wide standard deviation in direct DNA
damage levels; however a statistical difference was still achieved
between DNA damage in the AA (1.4460.19) versus the
AG (0.8160.06) and GG (0.8860.04) alleles. While no QQ
Table 2. Biomarkers of Oxidative Stress and Damage by Study Arm.a
Pancreatic Cancer Cases
(n=31)
Healthy Unrelated
Control (n= 20)
Healthy Related Control
(n =20)
Cancer v. Unrelated
Control
Cancer v. Related
Control
Adjusted Mean ± SE Adjusted Mean ± SE Adjusted Mean ± SE p-value p-value
TACb (mM) 4.5060.08 4.5560.10 4.4360.11 0.66 0.65
Direct DNA Damagec 1.0060.05 0.7060.06 0.8260.07 ,0.001 0.046
Oxidative DNA Damage 1.7960.14 1.5660.17 1.4360.19 0.26 0.15
MDAd (mM) 1.2460.05 1.2260.06 1.1560.07 0.81 0.33
aAdjusted for age and sex;
bTAC= Total antioxidant capacity;
cDNA damage (direct and oxidative is expressed as Comet (Olive) tail moment: [(tail mean – head mean)*tail%DNA/100];
dMDA=malondialdehyde.
doi:10.1371/journal.pone.0090052.t002
Table 3. Correlation Between Oxidative Stress/Damage Markers and Environmental Factorsa.
n TAC (mM) Direct DNA Damage
Oxidative DNA
Damage MDA (mM)
Adjusted Mean ± SE Adjusted Mean ± SE Adjusted Mean ± SE Adjusted Mean ± SE
Smokingb p = .64 p = .38 p = .34 p = .50
Never 33 4.4860.08 0.9060.05 1.5260.15 1.2160.05
Former 19 4.4860.10 0.8060.06 1.8860.19 1.1460.07
Current 14 4.6060.12 0.8060.07 1.6460.21 1.2560.07
Chronic Pancreatitisc p = .21 p = .96 p = .75 p = .81
Yes 8 4.6860.16 0.8660.10 1.7360.28 1.1960.10
No 60 4.4660.06 0.8660.04 1.6360.11 1.2260.04
Inflammatory Conditionsc p = .77 p = .08 p = .25 p = .048
Yes 19 4.5260.10 0.9660.06 1.4860.18 1.3260.07
No 49 4.4860.07 0.8260.04 1.7260.12 1.1660.04
rs rs rs rs
Pack Years 66 0.18 p = .18 20.29 p = .02 0.03 p = .86 20.04 p = .75
Days Drinking Alcohol in past Yearb 66 0.03 p = .82 0.18 p = .15 20.03 p = .78 20.17 p = .16
aAdjusted for age and sex;
bMissing data for 2 pancreatic cancer cases; 1 healthy unrelated control; and 2 healthy related controls;
cMissing data for 1 pancreatic cancer case; 1 healthy unrelated control; and 1 healthy related controls.
doi:10.1371/journal.pone.0090052.t003
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homozygous individuals were present in this study, heterozygous
ERCC4 R415Q subjects exhibited elevated DNA damage versus
RR individuals (1.1260.10 and 0.8460.04 respectively).
Discussion
The etiology of sporadic pancreatic cancer remains largely
unknown; however, epidemiologic studies have identified risk
factors that contribute to the development of pancreatic carcino-
mas. These factors include environmental and lifestyle factors,
such as smoking, drinking and diet, and inflammatory conditions
such as diabetes and pancreatitis, all of which share the ability to
generate oxidative stress and DNA damage. The present pilot
study was designed to examine the contribution of environment
and genetics to an individual’s level of oxidative stress and DNA
damage and the subsequent risk for development of pancreatic
cancer. To accomplish this objective, we utilized three groups of
subjects; a pancreatic cancer cohort, a healthy unrelated control
group living with the case subject, and a healthy genetically related
control group which did not reside with the case. We found
evidence to suggest that both environment and genetics contribute
to the oxidative stress and DNA damage observed in cases and
controls in our study.
Oxidative stress and DNA damage were evaluated using four
measurements: TAC, direct and oxidative DNA damage mea-
sured in circulating PBMCs, and MDA levels. These parameters
have previously been investigated in human diabetic subjects and
in an animal model of diabetes [13,14,28,29]; however, to date this
is the first report of these parameters in pancreatic cancer patients.
In type 2 diabetic patients, decreased TAC and increased plasma
MDA was observed, compared to subjects with normal glucose
tolerance [14]. We found that both cases and unrelated controls
exhibited similar mean levels of TAC, MDA, and oxidative DNA
damage while there were greater, though not significant, mean
differences in pancreatic cancer subjects in comparison to healthy
related controls (Table 2). It is possible that the upregulation of
TAC seen in the pancreatic cancer cases may be due to smoking,
since the percentage of current and former smokers compared to
never smokers was higher in cases versus healthy related controls
(Table 1). In addition, we observed a positive correlation of TAC
with pack years (Table 3). Smoking has been shown in some
studies to increase the activity of antioxidant enzymes [30,31],
which would lead to increased TAC.
One of the most significant observations in this study was an
increased level of direct DNA damage in the pancreatic cancer
group compared to both control groups (Table 2). This
observation may be related to the increased incidence of
inflammatory conditions observed among cases (Table 1). Our
results are consistent with the increased direct DNA damage
previously reported in diabetes, which is an inflammatory
condition [13,14,28]. Oxidative damage to bases can be deter-
mined using modified Comet assays, which use repair endonucle-
ases to assess specific types of damage. An increase in endonu-
clease III-sensitive sites, indicative of oxidized pyrimidine bases,
was observed in type 2 diabetes, while an increase in fpg-sensitive
sites, indicative of oxidized purines, was found in some but not all
Table 4. Significance of SNP Expression in Pancreatic Cancer Cases vs. Healthy Unrelated Control.
p Values
Function Gene Change rs # Overall Dominance Recessive Gene Dose
Inflammation TNFA 2308 G.A 1800629 0.875 1.000 1.000 1.000
TLR4 D299G 4986790 0.077 0.514 0.411 1.000
T399I 4986791 0.264 0.514 0.668 1.000
Oxidative Stress SOD2 A16V 4880 0.573 0.456 0.755 1.000
GSTM1 K173N 1065411 0.836 0.685 0.657 0.657
GSTM3 V224I 7483 0.797 1.000 0.545 0.676
NOS3 D298E 1799983 0.835 1.000 0.773 0.647
CAT 221 A.T 7943316 0.511 0.389 0.384 0.277
2262 C.T 1001179 0.815 0.640 1.000 1.000
DNA damage APEX1 I64V 2307486 1.000 –a 1.000 1.000
Q51H 1048945 0.640 0.640 –a 1.000
OGG1 S236C 1052133 0.856 0.767 0.565 0.676
ERCC2 D312N 1799793 0.697 0.514 0.778 0.622
D711D 1052555 0.204 0.566 0.143 0.206
Q751K 13181 0.513 0.567 0.384 0.308
ERCC4 R415Q 1800067 0.070 0.070 –a 0.070
XRCC1 Q399R 25487 0.923 1.000 0.773 0.675
ATM D1853N 1801516 1.000 1.000 1.000 0.779
Methionine/folate metabolism MTRR H595Y 10380 1.000 1.000 1.000 1.000
MTHFR A222V 1801133 0.502 1.000 0.249 0.456
Metabolism CYP2A6 L160H 1801272 0.029 0.029 0.055 0.016
UGT1A7 W208R 1.2E+07 0.892 0.778 1.000 0.802
a– = no corresponding dominant (or recessive) nucleotide.
doi:10.1371/journal.pone.0090052.t004
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studies [13,28,29]. In our study, while fpg-modified oxidative
DNA damage was higher in pancreatic cancer patients compared
to both control groups, the increase was not statistically significant.
Together, our results indicate that a component of oxidative stress
and DNA damage may be environmentally-related, as both cases
and unrelated healthy controls exhibit similar levels of TAC,
MDA and oxidative DNA damage. However, the environment
alone cannot account for the difference observed in direct DNA
damage, as these were significantly elevated in pancreatic cancer
cases versus both control groups.
We next looked at the contribution of genetics as a modifier of
pancreatic cancer risk. We focused our analysis on pathways
related to known pancreatic cancer risk factors: carcinogen
metabolism, inflammation, and DNA damage and repair.
Cigarette smoke can generate free radicals and oxidants which
can lead to increased oxidative stress while it also contains
procarcinogenic compounds that can be metabolized to potent
carcinogens. While correlations between smoking and oxidative
stress biomarkers were not observed, an association was seen
between pancreatic cancer and the CYP2A6 L160H polymor-
phism. Among its diverse substrates, CYP2A6 catalyzes the
metabolism of nicotine and tobacco-specific procarcinogens, such
as 4-(methylnitrosamine)-a-(3-pyridyl)-1-butanone or NNK [32].
CYP2A6 expression and activity levels are highly variable in
individuals, largely due to genetic polymorphisms. High enzymatic
activity of CYP2A6 has been associated with lung, esophageal and
colorectal cancer [32,33]. The L160H polymorphism in CYP2A6
results in the expression of a protein with no enzymatic activity
[34]. Individuals who possess the CYP2A6 His variant would be
unable to activate procarcinogens in cigarette smoke and thus
would be protected against cancer development, a finding that has
been shown in lung cancer [35]. In our study, we found that the
majority (97%) of pancreatic cancer cases possess the enzymati-
cally active homozygous AA CYP2A6 allele compared to 75% and
89% of the healthy unrelated and related controls, respectively
(Table S1). These results are in agreement with a recent study
which found an 80% increased risk for development of pancreatic
cancer in individuals who exhibited the highest quartile of
CYP2A6 activity [36].
Overexpression of tumor necrosis factor alpha (TNFA), a pro-
inflammatory cytokine, has been implicated in autoimmune
diseases and cancers associated with an inflammatory component
[37,38]. In this study, chronic pancreatitis and other inflammatory
conditions were more prevalent in the pancreatic cancer cases
(Table 1). In addition, elevated MDA levels were significantly
associated with inflammatory conditions, and direct DNA damage
approached statistical significance in individuals with inflamma-
tory conditions (Table 3). The A allele at position 2308 in the
TNFA gene promoter has been shown to correlate with elevated
TNFa expression [38]. In a previous study of pancreatic cancer
patients, pancreatitis was associated with 2308 TNFA GA + AA
alleles; however, no overall association with pancreatic cancer was
seen [39]. In addition, the 2308A allele conferred a 2-fold risk for
development of type 2 diabetes [40]. In the present study, we
found an association between the homozygous 2308 A TNFA
allele and direct DNA damage (Table 5 and 6); however,
consistent with previous studies [39], we did not observe an
Table 5. Correlation of SNPs with Direct DNA Damage.
SNP Genotype p values
Dominance Recessive Gene Dose
TNFA(2308G.A) AA AG GG 0.877 0.003 0.408
TLR4(D299G) AA AG GG 0.881 0.243 0.390
TLR4(T399I) CC CT TT 0.881 0.105 0.240
SOD2(A16V) AA AG GG 0.752 0.682 0.654
GSTM1(K173N) CC CG GG 0.310 0.097 0.169
GSTM3(V224I) CC CT TT 0.541 0.817 0.631
NOS3(D298E) GG GT TT 0.561 0.638 0.534
CAT (221A.T) AA AT TT 0.530 0.792 0.730
CAT (2262C.T) CC CT TT 0.665 0.603 0.561
APEX1(I64V) AA AG GG –a 0.234 0.234
APEX1(Q51H) CC CG GG 0.414 –a 0.414
OGG1(S326C) CC CG GG 0.073 0.135 0.097
ERCC2(D312N) GG GA AA 0.144 0.152 0.073
ERCC2(D711D) AA AG AA 0..097 0.560 0.116
ERCC2(Q751K) GG GT TT 0.292 0.813 0.476
ERCC4(R415Q) AA AG GG 0.009 –a 0.009
XRCC1(Q399R) CC CT TT 0.629 0.305 0.331
ATM(D1853N) AA AG GG 0.397 0.849 0.394
MTRR(H595Y) CC CT TT 0.334 0.396 0.301
MTHFR(A222V) GG GA AA 0.207 0.330 0.181
CYP2A6(L160H) TT TA AA 0.765 0.857 0.906
UGT1A7(W208R) CC CT TT 0.340 0.400 0.249
a– = no corresponding dominant (or recessive) nucleotide.
doi:10.1371/journal.pone.0090052.t005
Table 6. Correlation of Genotype with Direct DNA Damagea.
Gene SNP Nucleotide Amino Acid n
Direct DNA Damage
Adjusted Mean ± SE
TNFA 2308 G.A AA – 2 1.4460.19b
AG – 19 0.8160.06
GG – 50 0.8860.04
ERCC4 R415Q AA QQ 0 –
AG RQ 8 1.1260.10b
GG RR 63 0.8460.04
aAdjusted for age and sex;
bStatistically different from other genotypes (p,0.05);
doi:10.1371/journal.pone.0090052.t006
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association with pancreatic cancer (Table 4). These results suggest
that individuals harboring the 2308 A TNFA allele may be prone
to develop chronic inflammatory conditions, which may lead to
DNA damage and pancreatic cancer.
In our study, DNA damage in PBMCs was significantly elevated
in pancreatic cancer patients (Table 3). Repair of damaged DNA
is critical for prevention of DNA mispairing, genomic instability
and DNA strand breaks. The BER pathway repairs oxidatively
damaged DNA bases and modifications which do not distort the
overall DNA structure, while the NER pathway repairs damage
resulting from bulky adducts and those that distort the DNA helix,
such as those caused by tobacco-related carcinogens. Multiple
studies support a role for SNPs in both the NER and BER
pathways in pancreatic cancer [18,19,21,22]. ERCC4 is part of
the ERCC1-ERCC4 endonuclease complex involved in the NER
pathway [41,42]. While homozygous R415Q ERCC4 minor alleles
(AA) have been associated with increased risk of breast cancer in
several studies [43,44], carriers of one or two minor alleles were
found to have a decreased risk for pancreatic cancer [21]. The
effect of the R415Q ERCC4 polymorphism on enzyme activity has
not been firmly established; however, modeling programs have
predicted that the R415Q change would negatively impact protein
function and repair capacity [21]. In our study, the RQ415 allele
was associated with increased direct DNA damage. Of the 8
individuals which possessed the heterozygous alleles and displayed
elevated DNA damage, 6 were pancreatic cancer cases and 2 were
healthy related control subjects (Table 6), suggesting that the
increased DNA damage observed in the ERCC4 R415Q
heterozygotes contributes to development of pancreatic cancer.
This is in agreement with a recent study showing that heterozy-
gous R415Q ERCC4 was associated with benign breast disease, a
known breast cancer precursor [45].
While these results show associations of DNA damage with
pancreatic cancer and an association of DNA damage with
selective SNPs, several limitations exist in our study. The low
frequency of rare alleles for some SNPs may lead to spurious
results whereby recruitment of additional subjects will be required
to validate these findings. Recall bias may have led to misclassi-
fication of subjects into environmental lifestyle groups, as many of
the identified pancreatic cancer risk factors (ie smoking, drinking)
were self-reported. Age was significantly lower in the healthy
related control group compared to pancreatic cancer subjects.
Since increased DNA damage has been observed with aging [12],
we have adjusted for age in our analyses. However, age differences
cannot account for the observed association between direct DNA
damage and pancreatic cancer, as age range of the cases and
healthy unrelated controls was similar. All of our subjects were
Caucasian, such that these findings may not extend to other ethnic
groups. Our study investigated the involvement of polymorphisms
in only a small subset of genes; thus many potential gene-gene
interactions and gene-environment interactions remain to be
studied.
The use of two control groups in this study enabled the
investigation of the contribution of environment to pancreatic
cancer in a unique way; control subjects who reside with cases are
more likely to share the same lifestyle exposures, as opposed to
controls that are matched to cases by questionnaire data alone. In
addition, these potential exposures are likely to have been shared
for a considerable amount of time which enables a more accurate
assessment of the contribution of individual factors to pancreatic
cancer development. Overall, results from this pilot study support
a role of both genetics and environmental/lifestyle factors in the
development of pancreatic cancer. We report an association of
pancreatic cancer with DNA damage and associations with
specific polymorphisms in genes involved in metabolism (CYP2A6),
inflammation (TNFA), and DNA damage and repair (ERCC4).
Evaluating DNA damage in circulating PBMCs, as well as select
genotyping strategies may thus provide an important screening
tool to identify individuals at an increased risk for developing
pancreatic cancer. Due to the small sample size in this pilot study,
assessment of these endpoints in additional pancreatic cancer and
control subjects is needed. In addition, mechanistic studies of
individual SNPs in CYP2A6, TNFA and ERCC4 genes would be
useful to assess their contribution to the development of pancreatic
cancer.
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